INSIGHTS ON CRITICAL ENVIRONMENTS

• Optimizing Cleanroom Cleaning And Disinfection To Meet Annex 1 Requirements

  Explore Annex 1 updates on contamination control in pharmaceutical cleanrooms, emphasizing cleaning consistency, training, advanced tools, and technologies to achieve regulatory compliance.

• Accelerating Small Molecule Development With Cutting-Edge Technology

  Discover Asymchem Sandwich, our advanced small molecule facility at Discovery Park, Kent. 

• Protecting Product Integrity Through Cold Chain

  Reliable temperature‑controlled storage, monitoring, and safeguards keep sensitive materials stable from fill to patient, protecting quality, preventing degradation, and ensuring safety throughout the cold chain.

• Developing A Method To Assess Product And Personnel Safety In vH2O2 Decontamination Cycles

  Discover how ultra-sensitive spectroscopy transforms decontamination validation, revealing hidden efficiencies that safely cut facility downtime while ensuring absolute safety.

• Final Filtration In Chemical Processing

  6/22/2026

  Ensure chemical product quality with effective final filtration that removes particles and contaminants, boosts efficiency, and meets strict purity requirements across demanding applications.

• Compressed Gas Risk Assessment: A Significant Step In Your CCS

  10/10/2024

  Discover the importance of compressed gas monitoring in ensuring product quality and compliance with EU GMP standards.

• Maintaining A State Of Control: EM And DES In Biopharma

  4/9/2026

  Partner with a proven team to streamline your facility validation and environmental monitoring programs with flexible, cGMP-compliant services and reliable on-site collection.

• Optimal Microbial Sampling Criteria

  6/24/2025

  Microbiological sampling ensures sterile conditions through surface, passive, and active air methods. The EU GMP Annex 1 emphasizes integrating these for comprehensive environmental monitoring.

• Minimizing Particulate Risk

  5/13/2026

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.